Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Inovio Pharma (NQ: INO ) 5.450 +0.170 (+3.22%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 233,630 Open 5.300 Bid (Size) 5.350 (1) Ask (Size) 5.690 (2) Prev. Close 5.280 Today's Range 5.300 - 5.560 52wk Range 3.888 - 14.75 Shares Outstanding 210,356,896 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News The Analyst Verdict: Inovio Pharmaceuticals In The Eyes Of 4 Experts October 04, 2024 Via Benzinga Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031 September 04, 2024 EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NYSE:PFE),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END Via FinancialNewsMedia Exposures COVID-19 Performance YTD -19.47% -19.47% 1 Month -3.71% -3.71% 3 Month -42.57% -42.57% 6 Month -54.96% -54.96% 1 Year +16.45% +16.45% More News Read More Inovio Pharmaceuticals (INO) Q2 2024 Earnings Call Transcript August 09, 2024 Via The Motley Fool Topics Earnings Exposures Financial INO Stock Earnings: Inovio Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024 August 08, 2024 Via InvestorPlace Peering Into Inovio Pharmaceuticals's Recent Short Interest March 11, 2024 Via Benzinga Recap: Inovio Pharmaceuticals Q4 Earnings March 06, 2024 Via Benzinga Preview: Inovio Pharmaceuticals's Earnings March 05, 2024 Via Benzinga Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031 September 04, 2024 From FN Media Group LLC Via GlobeNewswire Better Buy: Inovio Pharmaceuticals vs. Novavax May 22, 2024 Via The Motley Fool Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session May 20, 2024 Via Benzinga DNA Medicine Focused INOVIO Pharma Efficiencies Implemented By Leadership Will Help De-Risk Its Platform Technology: Analyst May 14, 2024 Via Benzinga Exposures Product Safety Inovio Pharmaceuticals (INO) Q1 2024 Earnings Call Transcript May 13, 2024 Via The Motley Fool Topics Earnings Exposures Financial INO Stock Earnings: Inovio Pharmaceuticals Misses EPS for Q1 2024 May 13, 2024 Via InvestorPlace This Under-the-Radar Stock Is Up by 96% This Year: Time to Buy? May 05, 2024 Via The Motley Fool Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 16, 2024 Via Benzinga Inovio Pharmaceuticals Stock Is Diving Today: What's Happening? April 16, 2024 Via Benzinga Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket April 16, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session April 16, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday April 16, 2024 Via InvestorPlace Live Nation Entertainment, Groupon And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session April 16, 2024 Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Friday's After-Market Session April 05, 2024 Via Benzinga Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript March 06, 2024 Via The Motley Fool Topics Earnings Exposures Financial INO Stock Earnings: Inovio Pharmaceuticals Beats EPS, Misses Revenue for Q4 2023 March 06, 2024 Via InvestorPlace Victoria's Secret, Inovio Pharmaceuticals, Broadcom, Aptorum Group, Tesla: Why These 5 Stocks Are On Investors' Radars Today March 06, 2024 Via Benzinga Topics Stocks Exposures US Equities Earnings Scheduled For March 6, 2024 March 06, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.